Cargando…

Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus

Enteroviruses are believed to trigger or accelerate islet autoimmunity in genetically susceptible individuals, thereby resulting in loss of functional insulin-producing β-cells and type 1 diabetes mellitus (T1DM). Although enteroviruses are primarily involved in acute and lytic infections in vitro a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nekoua, Magloire Pandoua, Alidjinou, Enagnon Kazali, Hober, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157043/
https://www.ncbi.nlm.nih.gov/pubmed/35650334
http://dx.doi.org/10.1038/s41574-022-00688-1
_version_ 1784718564359405568
author Nekoua, Magloire Pandoua
Alidjinou, Enagnon Kazali
Hober, Didier
author_facet Nekoua, Magloire Pandoua
Alidjinou, Enagnon Kazali
Hober, Didier
author_sort Nekoua, Magloire Pandoua
collection PubMed
description Enteroviruses are believed to trigger or accelerate islet autoimmunity in genetically susceptible individuals, thereby resulting in loss of functional insulin-producing β-cells and type 1 diabetes mellitus (T1DM). Although enteroviruses are primarily involved in acute and lytic infections in vitro and in vivo, they can also establish a persistent infection. Prospective epidemiological studies have strongly associated the persistence of enteroviruses, especially coxsackievirus B (CVB), with the appearance of islet autoantibodies and an increased risk of T1DM. CVB can persist in pancreatic ductal and β-cells, which leads to structural or functional alterations of these cells, and to a chronic inflammatory response that promotes recruitment and activation of pre-existing autoreactive T cells and β-cell autoimmune destruction. CVB persistence in other sites, such as the intestine, blood cells and thymus, has been described; these sites could serve as a reservoir for infection or reinfection of the pancreas, and this persistence could have a role in the disturbance of tolerance to β-cells. This Review addresses the involvement of persistent enterovirus infection in triggering islet autoimmunity and T1DM, as well as current strategies to control enterovirus infections for preventing or reducing the risk of T1DM onset.
format Online
Article
Text
id pubmed-9157043
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-91570432022-06-02 Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus Nekoua, Magloire Pandoua Alidjinou, Enagnon Kazali Hober, Didier Nat Rev Endocrinol Review Article Enteroviruses are believed to trigger or accelerate islet autoimmunity in genetically susceptible individuals, thereby resulting in loss of functional insulin-producing β-cells and type 1 diabetes mellitus (T1DM). Although enteroviruses are primarily involved in acute and lytic infections in vitro and in vivo, they can also establish a persistent infection. Prospective epidemiological studies have strongly associated the persistence of enteroviruses, especially coxsackievirus B (CVB), with the appearance of islet autoantibodies and an increased risk of T1DM. CVB can persist in pancreatic ductal and β-cells, which leads to structural or functional alterations of these cells, and to a chronic inflammatory response that promotes recruitment and activation of pre-existing autoreactive T cells and β-cell autoimmune destruction. CVB persistence in other sites, such as the intestine, blood cells and thymus, has been described; these sites could serve as a reservoir for infection or reinfection of the pancreas, and this persistence could have a role in the disturbance of tolerance to β-cells. This Review addresses the involvement of persistent enterovirus infection in triggering islet autoimmunity and T1DM, as well as current strategies to control enterovirus infections for preventing or reducing the risk of T1DM onset. Nature Publishing Group UK 2022-06-01 2022 /pmc/articles/PMC9157043/ /pubmed/35650334 http://dx.doi.org/10.1038/s41574-022-00688-1 Text en © Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review Article
Nekoua, Magloire Pandoua
Alidjinou, Enagnon Kazali
Hober, Didier
Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus
title Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus
title_full Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus
title_fullStr Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus
title_full_unstemmed Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus
title_short Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus
title_sort persistent coxsackievirus b infection and pathogenesis of type 1 diabetes mellitus
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157043/
https://www.ncbi.nlm.nih.gov/pubmed/35650334
http://dx.doi.org/10.1038/s41574-022-00688-1
work_keys_str_mv AT nekouamagloirepandoua persistentcoxsackievirusbinfectionandpathogenesisoftype1diabetesmellitus
AT alidjinouenagnonkazali persistentcoxsackievirusbinfectionandpathogenesisoftype1diabetesmellitus
AT hoberdidier persistentcoxsackievirusbinfectionandpathogenesisoftype1diabetesmellitus